CoChat

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

The effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing immune checkpoint inhibitor treatment: a retrospective study

Open access

Abstract

Background: This study aimed to assess the effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing treatment with immune checkpoint inhibitors (ICIs). Methods: The medical records of 234 patients treated with ICIs for any type of solid cancer between February 2012 and May 2018 at the Seoul St. Mary’s Hospital were retrospectively reviewed. The data of patients who received antibiotics within 60 days before the initiation of ICI treatment were analyzed. The patients’ responses to ICI treatment and their survival were evaluated. Results: Non-small-cell lung carcinoma was the most common type of cancer. About half of the patients were treated with nivolumab (51.9%), and cephalosporin (35.2%) was the most commonly used class of antibiotics. The total objective response rate was 21%. Antibiotics use was associated with a decreased objective response (odds ratio 0.466, 95% confidence interval [CI] 0.225–0.968, p = 0.040). The antibiotics group exhibited shorter progression-free survival (PFS) and overall survival (OS) than the no antibiotics group (median PFS: 2 months vs. 4 months, p < 0.001; median OS: 5 months vs. 17 months, p < 0.001). In the multivariate analysis, antibiotics use was a significant predictor of patient survival (PFS: hazard ratio [HR] 1.715, 95% CI 1.264–2.326, p = 0.001; OS: HR 1.785, 95% CI 1.265–2.519, p = 0.001). Conclusions: The use of antibiotics may affect the clinical outcomes of patients with solid cancers treated with ICIs. Careful prescription of antibiotics is warranted in candidates who are scheduled for ICI treatment. Trial registration: Not applicable (retrospective study).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12885-019-6267-z

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Immune checkpoint inhibitors; treatment response in solid cancer
Fig. 1 Immune checkpoint inhibitors; treatment response in solid cancerCC BY · PubMed Central
Fig. 2 Survival curves and the impact of antibiotics in solid cancer patients treated with ICIs. ATB: antibiotics
Fig. 2 Survival curves and the impact of antibiotics in solid cancer patients treated with ICIs. ATB: antibioticsCC BY · PubMed Central
Fig. 3 Immune checkpoint inhibitors; treatment response in NSCLC
Fig. 3 Immune checkpoint inhibitors; treatment response in NSCLCCC BY · PubMed Central
Fig. 4 Survival curves and the impact of antibiotics in NSCLC patients treated with ICIs. ATB: antibiotics
Fig. 4 Survival curves and the impact of antibiotics in NSCLC patients treated with ICIs. ATB: antibioticsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 72

Metadata

Authors
Kim, H., Lee, J. E., Hong, S. H., Lee, M. A., Kang, J. H., & Kim, I.-H.
Affiliations
  • The Catholic University of Korea St. Vincent's Hospital (KR)
  • The Catholic University of Korea Seoul St. Mary's Hospital (KR)
Corresponding author
Kim, In-Ho
Venue
BMC Cancer
Published
2019-11-12
Volume
19
Issue
1
Pages
1100-1100
ISSN
1471-2407 (ISSN-L)
OpenAlex
W2987253676
Cited by
72
References
31
Citations by year
2026: 12 · 2025: 6 · 2024: 8 · 2023: 14 · 2022: 12 · 2021: 15 · 2020: 5
FWCI
3.34
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Research Foundation of Korea (NRF-2018R1C1B6008724)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Keywords
antibiotics, immune checkpoint inhibitors, solid tumors, nivolumab, objective response rate, progression-free survival, overall survival, non-small cell lung cancer, cephalosporins
MeSH terms
Antineoplastic Agents, Immunological, Anti-Bacterial Agents, Drug Interactions, Female, Humans, Male, Neoplasms, Prognosis, Retrospective Studies, Biomarkers, Tumor, Odds Ratio, Survival Analysis, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing immune checkpoint inhibitor treatment: a retrospective study. https://app.cochat.ai/papers/10.1186/s12885-019-6267-z
The paper
Kim, H., Lee, J. E., Hong, S. H., Lee, M. A., Kang, J. H., & Kim, I.-H. (2019). The effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing immune checkpoint inhibitor treatment: a retrospective study. BMC Cancer. https://doi.org/10.1186/s12885-019-6267-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.